Canada markets closed

Tempest Therapeutics, Inc. (TPST)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
3.6900+0.1500 (+4.24%)
At close: 04:00PM EDT
3.7489 +0.06 (+1.60%)
After hours: 07:50PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 81.98M
Enterprise Value 63.41M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)3.06
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -2.29

Trading Information

Stock Price History

Beta (5Y Monthly) -2.83
52-Week Change 372.68%
S&P500 52-Week Change 322.38%
52 Week High 39.7700
52 Week Low 30.1700
50-Day Moving Average 33.6933
200-Day Moving Average 32.9520

Share Statistics

Avg Vol (3 month) 3947.12k
Avg Vol (10 day) 3381.91k
Shares Outstanding 522.22M
Implied Shares Outstanding 622.22M
Float 817.78M
% Held by Insiders 10.06%
% Held by Institutions 129.04%
Shares Short (Apr 15, 2024) 41.13M
Short Ratio (Apr 15, 2024) 40.64
Short % of Float (Apr 15, 2024) 46.30%
Short % of Shares Outstanding (Apr 15, 2024) 45.07%
Shares Short (prior month Mar 15, 2024) 4766.84k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Dec 10, 2018
Ex-Dividend Date 4N/A
Last Split Factor 21:15
Last Split Date 3Jun 28, 2021

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-37.31%
Return on Equity (ttm)-131.42%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -28.78M
Net Income Avi to Common (ttm)-29.49M
Diluted EPS (ttm)-1.9100
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)39.23M
Total Cash Per Share (mrq)1.77
Total Debt (mrq)20.66M
Total Debt/Equity (mrq)77.18%
Current Ratio (mrq)4.29
Book Value Per Share (mrq)1.21

Cash Flow Statement

Operating Cash Flow (ttm)-27.36M
Levered Free Cash Flow (ttm)-17.47M